The importance of efficient, reliable decontamination of cleanrooms and other critical areas within the healthcare, pharmaceutical and biotech industries is undeniable. Having signed a UK distribution agreement with Mar Cor Purification, Cherwell Laboratories can now offer a range of dry fog technology and cold sterilant products to provide the ideal solution.

Cherwell Laboratories has built a reputation for providing high-quality products to meet the process validation and environmental monitoring requirements of the pharmaceutical and healthcare industries. The addition of Mar Cor Purification’s decontamination products complements the existing product portfolio enabling Cherwell to offer a comprehensive solution to customers. The new decontamination range, suitable for use in pharmaceutical cleanrooms and other critical areas, incorporates the highly effective Minncare^® Dry Fog and Mini Dry Fog systems plus Minncare and Actril Cold Sterilants.

Alongside the new decontamination range, Cherwell offers biological indicators for the validation of sterilisation processes, Redipor^® prepared microbiological media and SAS microbial air samplers. The range has been developed over time to meet the changing regulations within the pharmaceutical and related industries whilst maintaining Cherwell’s commitment to offering the highest quality products, expert advice and customer service levels.

“We are very excited to enter a UK distribution agreement with Mar Cor Purification,” said Andy Whittard, Managing Director, Cherwell Laboratories. “The Dry Fog and cold sterilant decontamination products provide an ideal synergy with Cherwell’s current product range, and meet our high expectations for product quality and customer service.”

For more information about Cherwell Laboratories, please visit www.cherwell-labs.co.uk or follow @CherwellLabs on Twitter.